Hence, new chemotherapy medicines, especially immunotherapy based on the target material have surprisingly been used in cancer treatments and patients with MMR-related cancer therapies, including those with Lynch syndrome with remarkable effects [13]. The gene discussed is MRC1; the disease is Lynch syndrome.